Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-01-28
2000-05-09
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514241, 544281, 544180, A61K 31505, C07D48704
Patent
active
060604786
ABSTRACT:
Corticotropin releasing factor (CRF) antagonists of formula I or II: ##STR1## and their use in treating anxiety, depression, and other psychiatric, neurological disorders as well as treatment of immunological, cardiovascular or heart-related diseases and colonic hypersensitivity associated with psychopathological disturbance and stress.
REFERENCES:
patent: 3910907 (1975-10-01), O'Brien et al.
patent: 3920652 (1975-11-01), Springer et al.
patent: 3995039 (1976-11-01), Rooney et al.
patent: 4021556 (1977-05-01), Springer et al.
patent: 4567263 (1986-01-01), Eicken et al.
patent: 4892576 (1990-01-01), Kruger et al.
patent: 4990647 (1991-02-01), Himmler et al.
patent: 4997940 (1991-03-01), Vinogradoff et al.
patent: 5089499 (1992-02-01), Barker et al.
patent: 5137887 (1992-08-01), Hashimoto et al.
patent: 5397774 (1995-03-01), Nugent et al.
patent: 5428044 (1995-06-01), Bantick et al.
patent: 5463071 (1995-10-01), Himmelsbach et al.
patent: 5464847 (1995-11-01), Courtemanche et al.
patent: 5484760 (1996-01-01), Bussler et al.
patent: 5486531 (1996-01-01), Schonafinger et al.
patent: 5723608 (1998-03-01), Yuan
Arch. Pharm. (Weinheim) 320, 487-491 (1987).
Psychopharmacology (Britton, Lee, Koob) 94:306-311 (1988).
Life Sciences (Britton, Koob, Rivier, Vale) 31:363-367 (1982).
Bull. Soc. Chim. Belg. (Maquestiau, Taghret, Eynde) vol. 101/No. 2/1992.
J. Med. Chem. (Senga, et al.) 25:243-249 (1982).
J. Med. Chem. (Senga, et al.) 25:243-249 (1982).
Synapse (Battaglia, Webster, De Souza), 1:572-581 (1987).
Science (Nemeroff, et al.) 226:1342 (1984).
Brain Research Reviews (Dunn, Berridge) 15:71-100 (1990).
Proc. Natl. Acad. Sci. (Rivier, Spiess, Vale) 80:4851-4855 (1983).
Recent Progress in Hormone Research (Vale, et al.) 39:245-271 (1983).
Journal of Neuroscience (De Souza, et al.) vol. 5, No. 12, p. 3189-3203 (1985).
Perspectives on Behavioral Medicine (Koob) 2:39-52 (1985).
Biol. Psychiatry (France, et al.) 23:86-88 (1988).
Hormones and Behavior (Berridge, Dunn) 21:393-401 (1987).
Hospital Practice (De Souza) p. 59-71 (1988).
Arch. Gen. Psychiatry (Sapolsky) 46:1047-1051 (1989).
Psychopharmacology (Britton, et al.) 86:170-174 (1985).
Biol. Psychiatry (Arato, et al.) 25:355-359 (1989).
Regulatory Peptides (Berridge, Dunn) 16:83-93 (1986).
Neuropsychopharmacology (Grigoriadis, et al.) vol. 2, No. 1, p. 53-60 (1989).
Psychopharmacology (Swerdlow, Geyer, Vale, Koob) 88:147-152 (1986).
Am. J. Psychiatry (Banki, et al.) 144:873-877 (1987).
Arch. Gen. Psychiatry (Nemeroff, et al.) 45:577-579 (1988).
New Eng. J. Med. (Gold, et al.) vol. 314, No. 21, p. 1329-1335 (1986).
Life Sciences (Morley, et al.) 41:527-544 (1987).
Physiological Reviews (Blalock) vol. 69, No. 1, p. 1-33 (1989).
Journal f.prakt. Chemie. (Joshi, Dubey) Band 321, Heft 2, p. 341-344 (1979).
Journal of Medicinal Chemistry (Springer, et al.) vol. 19, No. 2, p. 291-296 (1976).
J. Heterocyclic Chem. (O'Brien, et al.) 22:601-634 (1985).
J. Med. Chem. (Senga, Novinson, Wilson) 24:610-613 (1981).
Science, (Vale, et al.) 213:1394-1397 (1981).
Chemical Abstracts, vol. 67, No. 28, 1967, abstract # 108663r.
Chemical Abstracts, vol. 74, No. 28, 1971, abstract # 22867t.
Chemical Abstracts, vol. 74, No. 28, 1971, abstract # 22872r.
Chemical Abstracts, vol. 68, No. 28, 1968, abstract # 114635v.
Corticotropin Releasing Factor: Basic and Clinical Studies of a Neuropeptide (De Souza, Nemeroff) p. 221-224 (1990).
Comprehensive Organic Synthesis (Trost, Fleming) 3:481-520 (1991).
Comprehensive Organic Synthesis (Trost, Fleming) 7:762-769 (1991).
Remington's Pharmaceutical Sciences (Gennaro, ed.) 17.sup.th ed. P. 1418-1419 (1985).
Arvanitis Argyrios Georgios
Chorvat Robert
Gilligan Paul
Dupont Pharmaceuticals
Ford John M.
O'Brien Maureen P.
Rubin Kenneth B.
LandOfFree
Azolo triazines and pyrimidines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azolo triazines and pyrimidines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azolo triazines and pyrimidines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1065376